Literature DB >> 19032417

Optimal treatment for chronic active Epstein-Barr virus disease.

Jeffrey I Cohen.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19032417      PMCID： PMC2776035          DOI： 10.1111/j.1399-3046.2008.01095.x

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN： 1397-3142


× No keyword cloud information.
  38 in total

Review 1.  Epstein-Barr virus infection.

Authors:  J I Cohen
Journal:  N Engl J Med       Date:  2000-08-17       Impact factor: 91.245

2.  Clinical and virologic characteristics of chronic active Epstein-Barr virus infection.

Authors:  H Kimura; Y Hoshino; H Kanegane; I Tsuge; T Okamura; K Kawa; T Morishima
Journal:  Blood       Date:  2001-07-15       Impact factor: 22.113

3.  Two cases of chronic active Epstein-Barr virus infection in which EBV-specific cytotoxic T lymphocyte was induced after allogeneic bone marrow transplantation.

Authors:  Takako Miyamura; Kousuke Chayama; Tomoaki Wada; Kazunari Yamaguchi; Nobuko Yamashita; Toshiaki Ishida; Kana Washio; Naoto Morishita; Akira Manki; Megumi Oda; Tsuneo Morishima
Journal:  Pediatr Transplant       Date:  2008-02-06

4.  Unrelated bone marrow transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease.

Authors:  T Okamura; T Kishimoto; M Inoue; M Honda; N Yamashita; H Wakiguchi; M Yagita; G Hosoi; M Sako; M Yasui; K Yagi; K Kawa
Journal:  Bone Marrow Transplant       Date:  2003-01       Impact factor: 5.483

5.  Vidarabine therapy for severe chronic active Epstein-Barr virus infection.

Authors:  H Kimura; M Morita; I Tsuge; Y Hoshino; N Tanaka; Y Ito; T Morishima
Journal:  J Pediatr Hematol Oncol       Date:  2001 Jun-Jul       Impact factor: 1.289

6.  Impaired cytotoxic T lymphocyte response to Epstein-Barr virus-infected NK cells in patients with severe chronic active EBV infection.

Authors:  I Tsuge; T Morishima; H Kimura; K Kuzushima; H Matsuoka
Journal:  J Med Virol       Date:  2001-06       Impact factor: 2.327

7.  SH2D1A mutations in Japanese males with severe Epstein-Barr virus--associated illnesses.

Authors:  R Sumazaki; H Kanegane; M Osaki; T Fukushima; M Tsuchida; H Matsukura; K Shinozaki; H Kimura; A Matsui; T Miyawaki
Journal:  Blood       Date:  2001-08-15       Impact factor: 22.113

8.  Chronic active Epstein-Barr virus infection (CAEBV) successfully treated with allogeneic peripheral blood stem cell transplantation.

Authors:  T Taketani; A Kikuchi; J Inatomi; R Hanada; H Kawaguchi; K Ida; T Oh-Ishi; T Arai; H Kishimoto; K Yamamoto
Journal:  Bone Marrow Transplant       Date:  2002-03       Impact factor: 5.483

9.  Prognostic factors for chronic active Epstein-Barr virus infection.

Authors:  Hiroshi Kimura; Tsuneo Morishima; Hirokazu Kanegane; Shouichi Ohga; Yo Hoshino; Akihiko Maeda; Shosuke Imai; Motohiko Okano; Tomohiro Morio; Shumpei Yokota; Shigeru Tsuchiya; Akihiro Yachie; Shinsaku Imashuku; Keisei Kawa; Hiroshi Wakiguchi
Journal:  J Infect Dis       Date:  2003-01-28       Impact factor: 5.226

10.  Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infection.

Authors:  Barbara Savoldo; M Helen Huls; Zhensheng Liu; Takayuki Okamura; Hans-Dieter Volk; Petra Reinke; Robert Sabat; Nina Babel; James F Jones; Jennifer Webster-Cyriaque; Adrian P Gee; Malcolm K Brenner; Helen E Heslop; Cliona M Rooney
Journal:  Blood       Date:  2002-08-01       Impact factor: 22.113
View more
  18 in total

Review 1.  Progress and problems in understanding and managing primary Epstein-Barr virus infections.

Authors:  Oludare A Odumade; Kristin A Hogquist; Henry H Balfour
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

2.  A rare B-cell type chronic active Epstein-Barr virus infection patient mimicking lymphoma on 18F-FDG PET/CT and literature review.

Authors:  Hao Jiao; Yongbai Zhang; Zhao Chen; Xueqi Chen; Yongkang Qiu; Wenpeng Huang; Lin Nong; Lei Kang
Journal:  Am J Nucl Med Mol Imaging       Date:  2022-08-20

Review 3.  Epstein-Barr virus: more than 50 years old and still providing surprises.

Authors:  Lawrence S Young; Lee Fah Yap; Paul G Murray
Journal:  Nat Rev Cancer       Date:  2016-09-30       Impact factor: 60.716

4.  Recurrent scarring papulovesicular lesions on sun-exposed skin in a 22-year-old man.

Authors:  Melissa A Levoska; Jeffrey I Cohen; Irini Manoli; Chyi-Chia Richard Lee; Steven S T Ching; Jessica Shand; Deborah Tamura; Kenneth H Kraemer; John J DiGiovanna
Journal:  J Am Acad Dermatol       Date:  2017-09-28       Impact factor: 11.527

5.  Whole transcriptome profiling reveals major cell types in the cellular immune response against acute and chronic active Epstein-Barr virus infection.

Authors:  Huaqing Zhong; Xinran Hu; Andrew B Janowski; Gregory A Storch; Liyun Su; Lingfeng Cao; Jinsheng Yu; Jin Xu
Journal:  Sci Rep       Date:  2017-12-19       Impact factor: 4.379

6.  Dual Infection with Hepatitis B and Epstein-Barr Virus Presenting with Severe Jaundice, Coagulopathy, and Hepatitis B Virus Chronicity Outcome.

Authors:  Sirish C Rao; Imran Ashraf; Fazia Mir; Sami Samiullah; Jamal A Ibdah; Veysel Tahan
Journal:  Am J Case Rep       Date:  2017-02-16

Review 7.  The Evolution of Epigenetics: From Prokaryotes to Humans and Its Biological Consequences.

Authors:  Amber Willbanks; Meghan Leary; Molly Greenshields; Camila Tyminski; Sarah Heerboth; Karolina Lapinska; Kathryn Haskins; Sibaji Sarkar
Journal:  Genet Epigenet       Date:  2016-08-03

Review 8.  Herpes Simplex Virus Type 1 and Other Pathogens are Key Causative Factors in Sporadic Alzheimer's Disease.

Authors:  Steven A Harris; Elizabeth A Harris
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

9.  Immunization With Fc-Based Recombinant Epstein-Barr Virus gp350 Elicits Potent Neutralizing Humoral Immune Response in a BALB/c Mice Model.

Authors:  Bingchun Zhao; Xiao Zhang; Claude Krummenacher; Shuo Song; Ling Gao; Haojiong Zhang; Miao Xu; Lin Feng; Qisheng Feng; Musheng Zeng; Yuting Xu; Yixin Zeng
Journal:  Front Immunol       Date:  2018-05-01       Impact factor: 7.561

Review 10.  Chronic active Epstein-Barr virus infection of T-cell type, systemic form in an African migrant: case report and review of the literature on diagnostics standards and therapeutic options.

Authors:  Maxi Wass; Marcus Bauer; Roald Pfannes; Kerstin Lorenz; Andreas Odparlik; Lutz P Müller; Claudia Wickenhauser
Journal:  BMC Cancer       Date:  2018-10-03       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.